Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Farmers Insurance
US Army
Federal Trade Commission
Johnson and Johnson
Colorcon
Queensland Health
Chinese Patent Office
Deloitte

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204028

« Back to Dashboard

NDA 204028 describes DESVENLAFAXINE SUCCINATE, which is a drug marketed by Actavis Labs Fl, Alembic Pharms Ltd, Casi Pharms Inc, Lupin Ltd, Mylan Pharms Inc, West-ward Pharms Int, and Zydus Pharms Usa Inc, and is included in eight NDAs. It is available from thirteen suppliers. Additional details are available on the DESVENLAFAXINE SUCCINATE profile page.

The generic ingredient in DESVENLAFAXINE SUCCINATE is desvenlafaxine succinate. There are sixteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the desvenlafaxine succinate profile page.
Summary for 204028
Tradename:DESVENLAFAXINE SUCCINATE
Applicant:Casi Pharms Inc
Ingredient:desvenlafaxine succinate
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 204028

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 50MG BASE
Approval Date:Jun 29, 2015TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 100MG BASE
Approval Date:Jun 29, 2015TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Citi
Teva
Accenture
UBS
McKinsey
Daiichi Sankyo
Boehringer Ingelheim
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.